Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant

…

ANGLE inks £550,000 deal with AstraZeneca for prostate cancer detection, shares jump

ANGLE plc, the AIM-listed liquid biopsy company, has inked a major supplier agreement with pharmaceutical giant AstraZeneca. The £550,000 deal…

ANGLE teams up with AstraZeneca on a second assay

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to…

Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx

Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), QUALCOMM Incorporated (QCOM) and FedEx…

Calquence combination improved PFS in 1L MCL

02 May 2024 Calquence combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO…

Total Voting Rights

1 May 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

FTC challenges junk patents held by 10 drugmakers, including for Novo Nordisks Ozempic

The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.…

FTSE 100 continues record run boosted by Anglo American, AstraZeneca By Reuters

FTSE 100 continues record run boosted by Anglo American, AstraZeneca…

Truqap recommended for EU breast cancer approval

29 April 2024 Truqap plusFaslodex recommended for approval in the EU by CHMP for patients with advanced ER-positive breast cancer Recommendation based on CAPItello-291 results…

Enhertu improved PFS in HER2-low and ultralow

29 April 2024 Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one…

J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade

…

AstraZeneca: A Triple Shot Of Income, Growth, And Value

…

BHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more

Markets Defused aims to present an easy-to-understand and straightforward recap of the week’s most engaging stock market news BHP takeover approach…

Pharma Stock Roundup: MRK, SNY, AZN, NVS Q1 Results, Pipeline & Regulatory Updates

Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.…

Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron

The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly…

AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript

AZN earnings call for the period ending March 31, 2024.…

AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript

…

FIVE at FIVE: FTSE 100 retreats; AstraZeneca and Barclays impress; BHP eyes Anglo American; Meta sheds billions

1. FTSE 100 closes at fresh record high FTSE 100 closed at a new record high of 8,078.86 after it…

BHP Targets Rival Anglo American, Meta Earnings Spook Investors | Bloomberg Markets Today 04/25/2024

Mining giant BHP approaches rival Anglo American with a takeover offer in a move that could spark the biggest shakeup…

AstraZeneca zu alter Stärke erwacht! Pharma-Champion erfolgreich in das neue Jahr gestartet - Aktienanalyse

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

Astrazeneca: Europäischer Pharma-Champion begeistert

Ein massiver Rückgang des Geschäfts mit Corona-Impfstoffen hatte bei vielen Pharmaaktien in der Vergangenheit zu Kursrückgängen geführt, so auch bei…

JEFFERIES stuft ASTRAZENECA auf Hold

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Astrazeneca nach Quartalszahlen auf "Hold" mit einem Kursziel von 11000 Pence…

Non-Hodgkin Lymphoma Pipeline Landscape 2024: Analysis of Over 220 Potential Pharmaceuticals in Development

Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma - Pipeline Insight, 2024" report has been added…

Astrazeneca: Zahlen treiben Aktie an

AstraZeneca meldete trotz Rückgangs bei Corona-Medikamenten starke Q1-Ergebnisse.…

AstraZeneca shares jump on much stronger Q1 top and bottom line By Investing.com

AstraZeneca shares jump on much stronger Q1 top and bottom line…

FTSE 100 Live: Stocks steady, BHP swoops for Anglo American, Barclays and AstraZeneca lead results day

8.10am: Anglo receives ‘unsolicited’ cash offer from BHP Anglo American PLC (LSE:AAL) has confirmed a shock bid approach from BHP…

FTSE 100 Live: Index at record; Anglo American soars on BHP bid; Barclays, AstraZeneca up

FTSE 100 up 51 points to 8,092 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays rise 9.30am: Sainsbury’s non-food exposure…

FTSE 100 Live: Index hits record; Anglo American jumps on BHP bid

FTSE 100 up 53 points to 8,093 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays rise 11.45am AstraZeneca strips…

FTSE 100 Live: Stocks bounce higher, BHP swoops for Anglo American, Barclays and AstraZeneca lead results day

FTSE 100 up 32 points to 8,072 BHP makes bid for Anglo American AstraZeneca, Unilever and Barclays lead risers 8.28am: Stocks…

FTSE 100 Live: Stocks steady, AstraZeneca, LSEG, Unilever and Barclays lead big update day

7.09am: FTSE 100 seen flat in pre market Futures contracts have the footsie opening a couple of points lower at…

AstraZeneca beats first-quarter revenue, profit estimates By Reuters

AstraZeneca beats first-quarter revenue, profit estimates…

AstraZeneca beats first-quarter revenue, profit estimates

AstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by resilient demand for its oncology and rare…

1st Quarter Results

AstraZeneca 25 April 2024 Q1 2024 results Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery Revenue and…

Ihre wichtigsten Termine: Frische Q1-Zahlen von: Alphabet, Snap, Intel, AstraZeneca, Hermes und Nestle

AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up

AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease…

Day ahead: Sainsburys, Barclays, AstraZeneca

AstraZenecas CEOs pay has been the subject of much debate recently. See if Pascal Soriot is justifying his £18.7 million…

Britain’s Magnificent 7: Do Rolls-Royce, AstraZeneca and Unilever make the cut?

The Magnificent 7 will be hogging US financial news headlines over the coming weeks. Not to be confused with the…

ANGLE shares jump 30% on AstraZeneca tie-up

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) shares jumped 30% following the announcement of a strategic partnership with AstraZeneca PLC (LSE:AZN) that aims to advance...…

ANGLE partners with AstraZeneca in groundbreaking oncology contract

…

AstraZeneca: What The Markets Missing

…

Liquid biopsy firm Angle signs new commercial agreement with AstraZeneca

…

ANGLE inks AstraZeneca deal to develop ground-breaking cancer assay

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of liquid biopsy technologies, has partnered with AstraZeneca PLC (LSE:AZN) to enhance cancer drug...…

AstraZeneca (AZN) to Report Q1 Earnings: Heres What to Expect

Sales of AstraZenecas (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new…

Verhaltene Kauflaune bei Aktie von AstraZeneca plc (64,2491 €)

Wenig Kursbewegung aktuell bei dem Anteilsschein von AstraZeneca plc . Die Aktie notiert derzeit bei 68,39 US-Dollar. Kaum auffällig ist…

AstraZeneca PLCs (LON:AZN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

AstraZeneca (LON:AZN) has had a great run on the share market with its stock up by a significant 7.5% over…

Was AstraZeneca boss Soriot’s pay rise controversial? Not particularly

It was framed as a pitched battle between two opposing camps in AstraZeneca PLC (LSE:AZN)’s shareholder base. On one side,…

Friday papers: Amazon primed to hit $2tn stock market value

And AstraZeneca chief’s pay rise approved despite shareholder revolt.…

AstraZenecas (AZN) Fasenra Gets FDA Nod for Asthma in Kids

The FDA approves AstraZenecas (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11…

Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News

J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZenecas (AZN) Enhertu for metastatic HER2-positive solid tumors.…

AstraZeneca Shareholders Vote in Favor of £19 Million CEO Pay

AstraZeneca Plc shareholders backed a pay increase for Pascal Soriot, who is already the highest paid chief executive officer of…

dpa-AFX ProFeed